SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Tularik Inc. (TLRK)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (324)10/16/2002 9:30:12 AM
From: Czechsinthemail  Read Replies (1) of 598
 
They indicated there would be another IND by the end of this year and they plan to begin trials in the UK.

The other landmark was in their gene discovery program. They have now discovered 28 novel oncogenes and expect 2 more by year end. Of these, 5 have entered high throughput screening.

Regarding T487, they still haven't disclosed the target, but indicated that as far as they know, no one else has a compound for this target.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News